| Current Price | $3.84 | Mkt Cap | $130.5M |
|---|---|---|---|
| Open | $4.21 | P/E Ratio | 0.00 |
| Prev. Close | $3.84 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.81 - $4.21 | Volume | 340,225 |
| 52-Wk Range | $3.53 - $13.49 | Avg. Daily Vol. | 259,558 |
| Current Price | $3.84 | Mkt Cap | $130.5M |
|---|---|---|---|
| Open | $4.21 | P/E Ratio | 0.00 |
| Prev. Close | $3.84 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.81 - $4.21 | Volume | 340,225 |
| 52-Wk Range | $3.53 - $13.49 | Avg. Daily Vol. | 259,558 |
The best Bull and Bear pitches based on recency and number of recommendations.
With market expectations now at rock-bottom thanks to Friday's press release, I believe now is a good time to initiate a position in Celladon.
Read the most recent pitches from players about EIGR.
Recs
oscillation
(74.27)
Submitted: 5/28/2015 9:24:56 AM :
Start Price:
$32.40
NASDAQ:EIGR Score:
-191.31
nev
Recs
treasureoaks
(22.15)
Submitted: 4/22/2015 3:54:19 PM :
Start Price:
$203.85
NASDAQ:EIGR Score:
-202.92
Oversold.
Recs
Jimbyrnes1969
(< 20)
Submitted: 4/9/2015 1:25:22 PM :
Start Price:
$252.36
NASDAQ:EIGR Score:
-205.61
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock 300% in the short term but the real value will be when the therapy hits the market.
Find the members with the highest scoring picks in EIGR.
GreenAB (28.38) Score: +204.51
The Score Leader is the player with the highest score across all their picks in EIGR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| GreenAB | 28.38 | 3/20/2015 |
|
NS | $405.00 | -99.05% | +105.46% | +204.51 | 0 Comment | |
| IdahoInvestor | 28.34 | 8/17/2015 |
|
5Y | $15.75 | -75.62% | +106.69% | +182.31 | 0 Comment | |
| jon5555 | 91.46 | 9/29/2020 |
|
5Y | $8.29 | -53.68% | +29.46% | +83.14 | 0 Comment | |
| jonboy13 | 90.44 | 11/24/2021 |
|
5Y | $6.44 | -40.37% | -7.88% | +32.49 | 0 Comment | |
| Jonnyboy5555 | 73.48 | 1/7/2022 |
|
5Y | $4.93 | -22.11% | -7.80% | +14.31 | 0 Comment | |
| PAGEBOY2020 | 60.50 | 8/13/2021 |
|
5Y | $8.85 | -56.59% | -3.18% | -53.40 | 0 Comment | |
|
OneBee | 21.45 | 5/4/2021 |
|
3M | $8.67 | -55.71% | +3.67% | -59.38 | 0 Comment |
| foggs1 | 57.27 | 3/17/2021 |
|
5Y | $10.12 | -62.06% | +9.34% | -71.40 | 0 Comment | |
| odocoileus | < 20 | 9/10/2020 |
|
5Y | $10.48 | -63.36% | +28.79% | -92.15 | 0 Comment | |
| sikiliza | < 20 | 3/13/2020 |
|
5Y | $5.71 | -32.75% | +63.89% | -96.64 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
